Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermaheal Stem C'rum HL
- Development stage
- Unknown
- Lead developer
- Caregen
- Modality
- Peptides, Stem Cell Therapies → Cell Therapies
- Administration
- Subcutaneous, Topical
01
Overview
Dermaheal Stem C'rum HL is a specialized mesotherapy solution designed to treat hair loss and promote hair regrowth. Developed by the South Korean biotechnology company Caregen, the product utilizes a combination of adipose-derived stem cell conditioned media and synthetic biomimetic peptides. The formulation is intended to revitalize hair follicles, stimulate scalp blood circulation, and nourish the hair bulb by delivering growth factors that mimic natural biological signals. Key components include analogs of Insulin-like Growth Factor 1 (IGF-1), Basic Fibroblast Growth Factor (bFGF), and Vascular Endothelial Growth Factor (VEGF). These ingredients work together to transition hair follicles from the telogen (resting) phase to the anagen (growth) phase, increase follicle size, and inhibit apoptosis of follicular cells. It is primarily administered via mesotherapy or microneedling in clinical and aesthetic settings for patients with non-scarring alopecia and thinning hair.
- Brand names
- Dermaheal Stem C'rum HL
- Other names
- Dermaheal Stem Crum HL
02
Targets
IGF-1R (Insulin-like growth factor 1 receptor)FGFR3 (Fibroblast growth factor receptor 3)
Beyond the preview
Go deeper on Dermaheal Stem C'rum HL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermaheal Stem C'rum HL.